Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Change in Receivables (2016 - 2025)

Historic Change in Receivables for AtriCure (ATRC) over the last 16 years, with Q3 2025 value amounting to -$3.0 million.

  • AtriCure's Change in Receivables fell 23471.44% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year increase of 14977.92%. This contributed to the annual value of $8.3 million for FY2024, which is 1591.37% down from last year.
  • Per AtriCure's latest filing, its Change in Receivables stood at -$3.0 million for Q3 2025, which was down 23471.44% from $2.2 million recorded in Q2 2025.
  • AtriCure's 5-year Change in Receivables high stood at $8.0 million for Q1 2022, and its period low was -$3.0 million during Q3 2025.
  • Over the past 5 years, AtriCure's median Change in Receivables value was $2.2 million (recorded in 2025), while the average stood at $2.1 million.
  • In the last 5 years, AtriCure's Change in Receivables skyrocketed by 2320000.0% in 2023 and then plummeted by 23471.44% in 2025.
  • Over the past 5 years, AtriCure's Change in Receivables (Quarter) stood at -$496000.0 in 2021, then skyrocketed by 100.81% to $4000.0 in 2022, then skyrocketed by 23200.0% to $932000.0 in 2023, then surged by 550.54% to $6.1 million in 2024, then plummeted by 149.3% to -$3.0 million in 2025.
  • Its last three reported values are -$3.0 million in Q3 2025, $2.2 million for Q2 2025, and $2.7 million during Q1 2025.